Posted on Leave a comment

The Largest Unethical Medical Experiment in Human History – Georgia Institute of Technology

Georgia Tech Shidonna Raven Garden and Cook

Source: Georgia Institute of Technology
This monograph describes the largest unethical medical experiment in human history: the implementation and operation of non-ionizing non-visible EMF radiation (hereafter called wireless radiation) infrastructure for communications, surveillance, weaponry, and other applications. It is unethical because it violates the key ethical medical experiment requirement for “informed consent” by the overwhelming majority of the participants. The monograph provides background on unethical medical research/experimentation, and frames the implementation of wireless radiation within that context. The monograph then identifies a wide spectrum of adverse effects of wireless radiation as reported in the premier biomedical literature for over seven decades. Even though many of these reported adverse effects are extremely severe, the true extent of their severity has been grossly underestimated. Most of the reported laboratory experiments that produced these effects are not reflective of the real-life environment in which wireless radiation operates. Many experiments do not include pulsing and modulation of the carrier signal, and most do not account for synergistic effects of other toxic stimuli acting in concert with the wireless radiation. These two additions greatly exacerbate the severity of the adverse effects from wireless radiation, and their neglect in current (and past) experimentation results in substantial under-estimation of the breadth and severity of adverse effects to be expected in a real-life situation. This lack of credible safety testing, combined with depriving the public of the opportunity to provide informed consent, contextualizes the wireless radiation infrastructure operation as an unethical medical experiment.

Indeed, at the hart of many unethical medical experiments is the lack of informed consent and the loss of consent. Would you recognize an unauthorized and unethical medical experiment if you saw one? What would it look like? How would one report it? In fact in the past some governments have been apart of unethical experiments. The most widely known of these in recent history were the experiments conducted by the Nazis.

Share your comments with the community by posting them below. Share the wealth of health with your friends and family by sharing this article with 3 people today. As always you are the best part of what we do. Keep sharing!

If these articles have been helpful to you and yours, give a donation to Shidonna Raven Garden and Cook Ezine today.

Posted on Leave a comment

Echinacea: Medicinal Benefits – Health Line

Echinacea shidonna raven garden and cook

Source: Health Line
Research on echinacea suggests that it offers several impressive health benefits.

Positive Effect on the Immune System

Echinacea is best known for its beneficial effects on the immune system.

Numerous studies have found that this plant may help your immune system combat infections and viruses, which could help you recover faster from illness (8Trusted Source9Trusted Source10Trusted Source).

That’s one reason why echinacea is often used to prevent or treat the common cold.

In fact, a review of 14 studies found that taking echinacea may lower the risk of developing colds by more than 50% and shorten the duration of colds by one and a half days (11Trusted Source).

However, many studies on this topic are poorly designed and show no real benefit. This makes it hard to know if any benefits on colds are from taking echinacea or simply from chance (12Trusted Source).

In short, while echinacea may boost immunity, its effects on the common cold are unclear.

May Lower Blood Sugar Levels

High blood sugar can raise your risk of serious health problems.

This includes type 2 diabetes, heart disease and several other chronic conditions.

Test-tube studies have found that echinacea plants may help lower blood sugar levels.

In a test-tube study, an Echinacea purpurea extract was shown to suppress enzymes that digest carbohydrates. This would reduce the amount of sugar entering your blood if consumed (13Trusted Source).

Other test-tube studies found that echinacea extracts made cells more sensitive to insulin’s effects by activating the PPAR-y receptor, a common target of diabetes drugs (14Trusted Source15).

This particular receptor works by removing excess fat in the blood, which is a risk factor for insulin resistance. This makes it easier for cells to respond to insulin and sugar (16Trusted Source).

Still, human-based research on the effects of echinacea on blood sugar is lacking.

May Reduce Feelings of Anxiety

Anxiety is a common problem that affects close to one in five American adults (17).

In recent years, echinacea plants have emerged as a potential aid for anxiety.

Research has discovered that echinacea plants contain compounds that may reduce feelings of anxiety. These include alkamides, rosmarinic acid and caffeic acid (18Trusted Source).

In one mouse study, three out of five echinacea samples helped reduce anxiety. In addition, they did not make the mice less active, in contrast to higher doses of standard treatments (18Trusted Source).

Another study found that Echinacea angustifolia extract rapidly reduced feelings of anxiety in both mice and humans (19Trusted Source).

However, as of now, only a handful of studies on echinacea and anxiety exist. More research is needed before echinacea products can be recommended as a possible treatment.

Anti-Inflammatory Properties

Inflammation is your body’s natural way of promoting healing and defending itself.

Sometimes inflammation can get out of hand and last for longer than necessary and expected. This may raise your risk of chronic diseases and other health problems.

Several studies have shown that echinacea can help reduce excess inflammation.

In a mouse study, echinacea compounds helped reduce important inflammatory markers and memory-loss caused by inflammation (20Trusted Source).

In another 30-day study, adults with osteoarthritis found that taking a supplement containing echinacea extract significantly reduced inflammation, chronic pain and swelling.

Interestingly, these adults did not respond well to conventional non-steroidal inflammatory drugs (NSAIDS) but found the supplement containing echinacea extract helpful (21Trusted Source).

May Help Treat Skin Concerns

Research has shown that echinacea plants may help treat common skin concerns.

In a test-tube study, scientists found that echinacea’s anti-inflammatory and anti-bacterial properties suppressed the growth of Propionibacterium, a common cause of acne (22Trusted Source).

In another study in 10 healthy people aged 25–40, skin care products containing echinacea extract were found to improve skin hydration and reduce wrinkles (23Trusted Source).

Similarly, a cream containing Echinacea purpurea extract was shown to improve eczema symptoms and help repair the skin’s thin, protective outer layer (24Trusted Source).

However, echinacea extract appears to have a short shelf life, making it difficult to incorporate into commercial skin care products.

May Offer Protection Against Cancer

Cancer is a disease that involves the uncontrolled growth of cells.

Test-tube studies have shown that echinacea extracts may suppress cancer cell growth and even trigger cancer cell death (25Trusted Source26Trusted Source).

In one test-tube study, an extract of Echinacea purpurea and chicoric acid (naturally found in echinacea plants) was shown to trigger cancer cell death (25Trusted Source).

In another test-tube study, extracts from echinacea plants (Echinacea purpurea, Echinacea angustifolia and Echinacea pallida) killed human cancer cells from the pancreas and colon by stimulating a process called apoptosis or controlled cell death (26Trusted Source).

It’s believed that this effect occurs due to echinacea’s immune-boosting properties (27Trusted Source).

There was some concern that echinacea could interact with conventional cancer treatments, such as doxorubicin, but newer studies have found no interaction (28Trusted Source29Trusted Source).

That being said, human studies are needed before making any recommendations.

SUMMARY

Echinacea has been shown to improve immunity, blood sugar, anxiety, inflammation and skin health. It may even have anti-cancer properties. However, human-based research on these benefits is often limited.

Potential Side Effects

Echinacea products appear to be safe and well-tolerated for short-term use.

There have been cases where people experienced side effects, such as (3Trusted Source):

  • Rashes
  • Itchy skin
  • Hives
  • Swelling
  • Stomach pain
  • Nausea
  • Shortness of breath

However, these side effects are more common among people with allergies to other flowers, such as daisies, chrysanthemums, marigolds, ragweed and more (3031Trusted Source).

As echinacea appears to stimulate the immune system, people with autoimmune disorders or people taking immunosuppressive drugs should avoid it or consult their doctors first (3Trusted Source).

While it appears to be safe for short-term use, its long-term effects are still relatively unknown.

SUMMARY

Echinacea appears to be safe and well tolerated in the short term, but its long-term effects are relatively unknown.

Dosage Recommendations

There is currently no official dosage recommendation for echinacea.

One reason being that findings from echinacea research are highly variable.

In addition, echinacea products often may not contain what is written on the label. One study found that 10% of echinacea products samples did not contain any echinacea (32Trusted Source).

This is why you should purchase echinacea products from trusted brands.

That said, research has found the following doses to be effective in aiding immunity (11Trusted Source):

  • Dry powdered extract: 300–500 mg of Echinacea purpurea, three times daily.
  • Liquid extract tinctures: 2.5 ml, three times daily, or up to 10 ml daily.

However, it’s best to follow the instructions that come with your specific supplement.

Keep in mind that these recommendations are for short-term use, as echinacea’s long-term effects on the body are still relatively unknown.

SUMMARY

Echinacea products are highly variable, which makes it hard to set a standard recommended dosage. The dosages vary with the form of echinacea you’re using.

The Bottom Line

Echinacea has been shown to improve immunity, blood sugar, anxiety, inflammation and skin health. It may even have anti-cancer properties. However, human-based research is often limited.

It’s considered safe and well tolerated for short-term use.

Suggested dosages vary depending on the form of echinacea you’re using.

Although it’s commonly used to treat the common cold, results in this area are mixed. While research has shown it may help prevent colds, shorten their duration or provide symptomatic relief, many studies have been poorly designed or shown no real benefit.

That said, there aren’t many products like echinacea with similar potential immune-boosting effects, so it might be worth trying it out.

During the pandemic many medical professionals are recommending immune boosting foods like echinace, vitamin c and d. What are you taking? How has it worked for you? Why do you take what you do?

Share your comments with the community by posting them below. Share the wealth of health with your friends and family by sharing this article with 3 people today. As always you are the best part of what we do. Keep sharing!

If these articles have been helpful to you and yours, give a donation to Shidonna Raven Garden and Cook Ezine today.

Posted on Leave a comment

Patients voice concerns after Chesapeake doctor arrested for health care fraud

Shidonna Raven Garden and Cook sharon-mccutcheon-unsplash

Source: WAVY News 10 | 11-09

CHESAPEAKE, Va. (WAVY) — A Chesapeake doctor was arrested on Friday for alleged health care fraud and false statements related to health care matters. Court documents say the Federal Bureau of Investigation started investigating 69-year-old Javaid Perwaiz in September 2018, when they received a tip from a hospital employee who suspected he was performing unnecessary surgeries on unsuspecting patients.

Would you recognize health care fraud if you saw it? Would you know if you were taking unnecessary medicine or had an unnecessary procedure? What would it look like?

Share your comments with the community by posting them below. Share the wealth of health with your friends and family by sharing this article with 3 people today. As always you are the best part of what we do. Keep sharing!

If these articles have been helpful to you and yours, give a donation to Shidonna Raven Garden and Cook Ezine today.

Posted on Leave a comment

Ethical or exploitative—should prisoners participate in COVID-19 vaccine trials?

Source: Science Mag
By Eli CahanSep. 14, 2020 , 1:50 PM

Science’s COVID-19 reporting is supported by the Pulitzer Center and the Heising-Simons Foundation.

As 38 clinical trials seek tens of thousands of volunteers to receive doses of experimental vaccines, researchers are discussing how to find and recruit participants effectively and ethically. Some people who are especially vulnerable to COVID-19 have not been well represented in studies—or represented at all. Prisoners, for instance, have borne a heavy burden of COVID-19, with more than 125,000 U.S. prisoners infected, and more than 1000 dead. But prisoners have also been excluded from the trials out of concern that they might be coerced into participating or exploited if they do.

Now, some researchers argue that including prisoners in studies could offer outsize health benefits. Correctional facilities have experienced many COVID-19 outbreaks and are structurally unsuited to social distancing (among other precautions). And so, the researchers argue, like other people at high risk of catching the disease, prisoners should be allowed to participate in clinical trials. 

ScienceInsider spoke with George Annas, a lawyer and bioethicist at Boston University, whose research addresses ethics and human rights in clinical trials, and Lauren Brinkley-Rubinstein, a sociologist and epidemiologist at the University of North Carolina, Chapel Hill, who studies management of infectious disease and substance abuse in incarcerated people. Both have published about health and ethics in holding facilities during the pandemic: In July, Annas wrote in The New England Journal of Medicine about inhumane medical practices in immigrant detention centers and, and in August, Brinkley-Rubinstein and colleagues argued in JAMA that prisoners should be included in vaccine trials.

This interview has been edited for brevity and clarity.

Q: What clinical research has been done historically in correctional facilities? Has it been done well?

George Annas: The history is pretty dark. It’s a history of research done without consent, without oversight, and without consequences. It starts in some respects with the Nazis, since Holocaust research—or pretend research, really—was done in prisoners to get scientific information for the German state. Another famous experience was John Charles Cutler’s 1940s experiments in Guatemalan prisons. In those experiments, prisoners were deliberately infected with gonorrhea, syphilis, and chancroid.

Lauren Brinkley-Rubinstein: There are lots of instances of prisoners being intentionally infected with diseases in order to develop new drugs, including malaria and hepatitis C. Horrible things happened at San Quentin [State Prison], including giving prisoners experimental testicular transplants. I think dark is the right word.

Q: Is any COVID-19 vaccine research taking place in correctional facilities? Has anyone put forward serious proposals to do such research?

L.B.R.: There was some conversation at the federal level at the initiation of large vaccine trials to include people involved in some way with the criminal justice system. My colleagues and I had a couple of phone calls with people involved in running those trials to see if it was something they’d entertain. There was some openness to it. But ultimately, including incarcerated populations felt too cumbersome. Between the ethical risks and the operational obstacles to actually get the sites up and running, it would have required a lot of extra effort.

G.A.: Up until recently, there’s really been no excuse to do research in these settings. But it’s a strange and perhaps intriguing group to study, because they’re almost definitely going to be exposed to the virus. So, it could give you answers you may not get if you trial the general population—who may not ever be exposed. That’s why we’re looking again. I’m not a big fan of prison research, but I am a big fan of science, so I think we should look at all these things again.

L.B.R.: Still, I think part of this conversation should be focused on people on probation or parole—the high-risk population that is criminal justice involved, but not presently incarcerated.

G.A.: Yeah. I’d be much more amenable to efforts to bring people on probation or parole into trials. They would be unshackled, literally, from some of the risks of exploitation we think about for prisoners who receive perks for “good” behavior and punishment for “bad” behavior.

Q: Could this kind of research actually benefit incarcerated people if they participate?

L.B.R.: It definitely could, assuming the vaccine works. Incarcerated people do have different risks, in terms of the barriers they face to getting certain elements of routine health care along with their potential to be exploited. But they also potentially would gain more from vaccination, given these settings are extreme amplifiers of infection.

G.A.: But the risk if an experimental vaccine doesn’t work is that these individuals won’t only be disappointed, but they’ll feel they were lied to or exploited.

L.B.R.: Another big part about why understanding these contexts is important is that we do eventually want vaccines to be made available to these populations. But there are lots of implementation issues that are very particular to jails and prisons. How do we store the vaccines under potentially very specific conditions? How do we monitor patients for side effects after injections? How we manage any needed follow-up, like a booster shot? We need to get expertise to optimize these programs when vaccines are eventually deployed. I don’t think that alone is justification to do a trial, but it is such a big part of vaccines being effective once they are approved. It’s something we’ll have to figure out.

Q: Could there be broader public health advantages for doing COVID-19 vaccine research in correctional facilities? Would experimental use of vaccines in correctional facilities benefit staff, neighboring communities, and more distant ones?

L.B.R.: If the experimental vaccines work, then the public health benefit of focusing vaccine resources—even during trials—on correctional facilities cannot be overemphasized. We’ve already seen that jail churn plays a tremendous role in community transmission.

G.A.: To me, it’s a different experiment. You can’t use community results to justify research on individuals. The risk-benefit analysis needs to come out right for the individual before they can consent to being in the trial.

Q: If such research is undertaken, how will we know whether ethical safeguards did enough to protect participants’ rights?

George Annas (left) and Lauren Brinkley-Rubinstein (right) GEORGE ANNAS AND LAUREN BRINKLEY-RUBINSTEIN

G.A.: There probably is no replacement for asking the participants themselves. Did they feel exploited? Did they feel used? Did they feel fulfilled? Did they feel part of something bigger?

L.B.R.: This is really at the crux of the issue. We’d have to ask, but also to appoint oversight boards that have prisoner representation. And we’d have to adopt other safeguards to ensure we are doing things ethically.

Q: Would giving prisoners the option to participate in a vaccine trial set a precedent for future research? What about continuing to withhold access?

G.A.: I think the question of “if not now, when?” is a very good one. We have a worldwide pandemic with a giant prisoner population that’s very susceptible to the disease and is dying from it. If we’re not going to permit research in that circumstance, we’re never going to permit it.

L.B.R.: Also, if we can figure out how to do this right—given the stakes right now—that could give back some element of power or respect that is otherwise not present in these places.

G.A.: It’s a question of whether we treat prisoners as human beings with agency, who are allowed to participate in something for the public good.

L.B.R.: Our approach to experimentation in prisons has been very binary: a history of serious abuses of power when we have run trials, versus the decision to completely avoid including prisoners in trials. We have to ask ourselves whether there’s a middle path.

G.A.: And considering a middle path, but then deciding it’s too much work—that would be an extreme position, too.

Q: As the prospect of an approved vaccine nears, fierce debate surrounds who should receive it first. According to current Centers for Disease Control and Prevention guidance, prisoners are not considered separate from the general population, putting them last in line. In contrast, a draft proposal released this month by the National Academies of Sciences, Engineering, and Medicine said prisoners should get vaccinated after health care workers, but before the general population. Where do you think incarcerated people belong on the priority list?

L.B.R.: Based on the evidence have about outbreaks, incarcerated people should be at the top tier. There’s a clear connection between what happens in these institutions and what happens in the community. When we have infections that spread in jails or prisons like wildfire, and staff going in and out and in and out, we’re making COVID infection more likely everywhere. If the only thing you cared about was your own health, you would still make the decision to prioritize them.

G.A.: People at the highest risk should receive the treatment first. That includes prisoners. It’s that simple, really. 

doi:10.1126/science.abe7861

As we are in the midst of the only Pandemic in recent history desperately in search of a vaccine, one must question the ethics employed in medical trails and the medical industries murky and dark history with experimentation not to mention fraud and scams. Without a current doubt those who find an effective vaccine will reap financial benefit. Every country on the globe is interested. Are you willing to take a vaccine? A health professional once stated, there is no profit in health. The profit is in disease. As many are trying to decided who should have the vaccine first and reporting in those population most affected by the corona virus, one must ask if these populations should also bare the brunt of clinical trials as well. Are clinical trials on unknowing and those not asked ever ethical and permissible?

Share your comments with the community by posting them below. Share the wealth of health with your friends and family by sharing this article with 3 people today. As always you are the best part of what we do. Keep sharing!

If these articles have been helpful to you and yours, give a donation to Shidonna Raven Garden and Cook Ezine today.

Posted on Leave a comment

Psychiatrist Sentenced to Prison for Healthcare Fraud Scheme – Norfolk, VA

fake shidonna raven garden and cook

FOR IMMEDIATE RELEASE Thursday, January 16, 2020

Source: US Department of Justice
NORFOLK, Va. – A Virginia Beach doctor was sentenced today to 27 months in prison for defrauding Medicare, Medicaid, and Tricare, and other health care benefits programs out of hundreds of thousands of dollars.

Additionally, Udaya K. Shetty, 64, agreed to pay over $1 million to settle related civil claims.

According to court documents, was a licensed psychiatrist practicing medicine at his own practice, Behavioral & Neuropsychiatric Group. Beginning in 2013, Shetty created a scheme by which he could overbill healthcare benefit programs by seeing patients for only five to 10 minutes, but then billing for services that were on average 41 to 63 minutes long. Shetty instructed his staff to often double, triple, or even quadruple book appointment times. The fraud became apparent when investigators discovered that on dozens of instances Shetty would need more than 24 hours a day of working to perform the services for which he billed. 

In 2017, Shetty closed his own practice and joined another psychiatric practice, Quietly Radiant Psychiatric Services. While there Shetty, and one of his former employees, Mary Otto, engaged in a similar scheme. Although other Quietly Radiant staff members were responsible for billing, Shetty directed Otto to access the billing system and change all of his billing data to a higher billing rate.  Otto complied and changed the data without the knowledge of Quietly Radiant’s staff. As a result of their actions, Shetty and Otto defrauded various healthcare benefit programs of more than $450,000. Otto pled guilty for her role in the scheme and was sentenced to 15 months in prison on January 10.

In regards to the civil settlement, Shetty agreed to pay $1,078,000 to the United States and the Commonwealth of Virginia to resolve his liability under the False Claims Act and the Virginia Fraud Against Taxpayers Act for submitting or causing the submission of false claims to the Medicare, Medicaid, and TRICARE programs.

G. Zachary Terwilliger, U.S. Attorney for the Eastern District of Virginia; Martin Culbreth, Special Agent in Charge of the FBI’s Norfolk Field Office; Robert E. Craig, Special Agent in Charge for the Defense Criminal Investigative Service’s (DCIS) Mid-Atlantic Field Office; Maureen R. Dixon, Special Agent in Charge of the Office of Inspector General for the U.S. Department of Health and Human Services (HHS); and Mark R. Herring, Attorney General of Virginia, made the announcement after sentencing by U.S. District Judge Rebecca Beach Smith. Assistant U.S. Attorney Joseph L. Kosky prosecuted the criminal case. Assistant U.S. Attorney Clare P. Wuerker handled the civil case.

A copy of this press release is located on the website of the U.S. Attorney’s Office for the Eastern District of Virginia. Related court documents and information are located on the website of the District Court for the Eastern District of Virginia or on PACER by searching for Case No. 2:19-cr-089.

Some patients often start off with private health care and end up with Medicaid, Medicare or Tricare because these government health insurance or more advantageous for those medical ‘professionals’ seeking to defraud patients and insurance providers. Would you recognize health care fraud if you see it? What does it look like? Have you been a victim of health care fraud?

Share your comments with the community by posting them below. Share the wealth of health with your friends and family by sharing this article with 3 people today. As always you are the best part of what we do. Keep sharing!

If these articles have been helpful to you and yours, give a donation to Shidonna Raven Garden and Cook Ezine today.

Posted on Leave a comment

COVID 19 Cases on the Rise: Your States Stats

covid 19 shidonna raven garden and cook

Source: Wavy 10 – Norfolk, VA, USA
WASHINGTON (NEXSTAR) — As coronavirus cases in the United States climb towards another peak, new daily cases have reached their highest point yet in 17 states, according to the New York Times.

On Thursday, new confirmed cases climbed over the 65,000 mark — a total the country hasn’t seen since the end of July. Additionally, we’re seeing cases rise in more than 45 states, according to a Times tracking tool.

The U.S. leads the world with 7.9 million coronavirus cases and some 217,000 confirmed deaths. Globally, there have been 39 million reported cases and 1.09 million confirmed deaths.Pfizer coronavirus vaccine won’t be available before Election Day, CEO confirms.

As the nation experiences a 25% increase in confirmed cases, here’s a look at the states that are seeing the highest percentage increases in COVID-19 cases:

States seeing case increases (by percentages):

  • New Mexico – Average of 457 cases per day, an increase of 123 percent from the average two weeks earlier.
  • Vermont – Average of nine cases per day, an increase of 110 percent from the average two weeks earlier.
  • New Hampshire – Average of 78 cases per day, an increase of 101 percent from the average two weeks earlier.
  • Montana – Average of 611 cases per day, an increase of 91 percent from the average two weeks earlier.
  • Connecticut – Average of 326 cases per day, an increase of 80 percent from the average two weeks earlier.
  • Indiana – Average of 1,655 cases per day, an increase of 66 percent from the average two weeks earlier.
  • Wyoming – Average of 183 cases per day, an increase of 65 percent from the average two weeks earlier.
  • Alaska – Average of 193 cases per day, an increase of 64 percent from the average two weeks earlier.
  • Rhode Island – Average of 199 cases per day, an increase of 63 percent from the average two weeks earlier.
  • Arizona – Average of 763 cases per day, an increase of 59 percent from the average two weeks earlier.
  • Colorado – Average of 894 cases per day, an increase of 57 percent from the average two weeks earlier.
  • Michigan – Average of 1,483 cases per day, an increase of 56 percent from the average two weeks earlier.
  • Nebraska – Average of 767 cases per day, an increase of 55 percent from the average two weeks earlier.
  • North Dakota – Average of 610 cases per day, an increase of 54 percent from the average two weeks earlier.
  • Ohio – Average of 1,654 cases per day, an increase of 53 percent from the average two weeks earlier.
  • South Dakota – Average of 653 cases per day, an increase of 50 percent from the average two weeks earlier.
  • Mississippi – Average of 760 cases per day, an increase of 49 percent from the average two weeks earlier.
  • Illinois – Average of 3,069 cases per day, an increase of 48 percent from the average two weeks earlier.
  • Virginia – Average of 1,058 cases per day, an increase of 42 percent from the average two weeks earlier.
  • Pennsylvania – Average of 1,362 cases per day, an increase of 39 percent from the average two weeks earlier.
  • Tennessee – Average of 1,870 cases per day, an increase of 38 percent from the average two weeks earlier.
  • Idaho – Average of 660 cases per day, an increase of 37 percent from the average two weeks earlier.
  • North Carolina – Average of 1,943 cases per day, an increase of 36 percent from the average two weeks earlier.
  • New Jersey – Average of 835 cases per day, an increase of 35 percent from the average two weeks earlier.
  • West Virginia – Average of 251 cases per day, an increase of 33 percent from the average two weeks earlier.
  • Nevada – Average of 587 cases per day, an increase of 30 percent from the average two weeks earlier.
  • New York – Average of 1,329 cases per day, an increase of 29 percent from the average two weeks earlier.
  • Washington – Average of 659 cases per day, an increase of 29 percent from the average two weeks earlier.
  • Minnesota – Average of 1,312 cases per day, an increase of 28 percent from the average two weeks earlier.
  • Kentucky – Average of 980 cases per day, an increase of 27 percent from the average two weeks earlier.
  • Missouri – Average of 1,916 cases per day, an increase of 27 percent from the average two weeks earlier.
  • Wisconsin – Average of 3,124 cases per day, an increase of 25 percent from the average two weeks earlier.
  • Utah – Average of 1,216 cases per day, an increase of 23 percent from the average two weeks earlier.
  • Alabama – Average of 1,027 cases per day, an increase of 21 percent from the average two weeks earlier.
  • Oregon – Average of 345 cases per day, an increase of 21 percent from the average two weeks earlier.
  • Massachusetts – Average of 663 cases per day, an increase of 20 percent from the average two weeks earlier.
  • Kansas – Average of 788 cases per day, an increase of 19 percent from the average two weeks earlier.
  • Florida – Average of 2,711 cases per day, an increase of 18 percent from the average two weeks earlier.
  • Oklahoma – Average of 1,182 cases per day, an increase of 16 percent from the average two weeks earlier.
  • Georgia – Average of 1,409 cases per day, an increase of 14 percent from the average two weeks earlier.
  • Iowa – Average of 1,044 cases per day, an increase of 13 percent from the average two weeks earlier.
  • South Carolina – Average of 907 cases per day, an increase of 13 percent from the average two weeks earlier.
  • Arkansas – Average of 911 cases per day, an increase of 11 percent from the average two weeks earlier.
  • Maryland – Average of 589 cases per day, an increase of 11 percent from the average two weeks earlier.
  • Texas – Average of 4,587 cases per day, an increase of 8 percent from the average two weeks earlier.
  • Louisiana – Average of 543 cases per day, an increase of 7 percent from the average two weeks earlier.
  • Delaware – Average of 125 cases per day, an increase of 5 percent from the average two weeks earlier.
  • California – Average of 3,285 cases per day, an increase of 2 percent from the average two weeks earlier.

States seeing case decreases (by percentages):

  • Hawaii – Average of 89 cases per day, a decrease of 17 percent from the average two weeks earlier.
  • Maine – Average of 28 cases per day, a decrease of 9 percent from the average two weeks earlier.

Just when we think we are coming out of this pandemic and we struggle to get back to normal after the economic crisis that came along with the pandemic, we see many states still struggling with COVID 19 cases Norfolk, VA, USA included. While our cases continue to fluctuate our state is not one of the states that was hit the hardest by COVID 19 cases. We took a cautious and measured approach and it paid dividends. In fact as factors, such as going back to school and mere weather change, now have to be factored in, some of the European countries that were fairing better in the crisis are now seeing new and emerging struggles with COVID 19. COVID 19 has definitely taken its place in history. What solutions have worked well for your state? How are people adjusting to having to spend more times in doors, which has lead to less social distancing, due primarily to weather change and an increase in COVID 19 cases across the globe? What are you winter plans and how do you plan to maintain social distancing measures and keep your immune system strong? Remember, healthy is the New Normal! States such as Hawaii and California may likely fair better than other states like New York and Vermont where citizens will be forced to spend more time indoors in the warmth bracing against the cold winter weather while Hawaii and California can still take advantage of the fresh circulating air outdoors and easier means of social distancing.

Share your comments with the community by posting them below. Share the wealth of health with your friends and family by sharing this article with 3 people today. As always you are the best part of what we do. Keep sharing!

If these articles have been helpful to you and yours, give a donation to Shidonna Raven Garden and Cook Ezine today.

Posted on Leave a comment

Coronavirus clinical trials are pausing over safety concerns – here’s what that means

covid 19 shidonna raven garden and cook

Source: CNBC
PUBLISHED THU, OCT 15 2020 6:00 AM EDT UPDATED THU, OCT 15 20209:02 PM EDT
Berkeley Lovelace Jr.@BERKELEYJR

  • J&J said Monday it paused the late-stage trial of its coronavirus vaccine candidate after a participant reported an “adverse event.”
  • Less than 24 hours later, Eli Lilly said its late-stage trial of its leading monoclonal antibody treatment for the coronavirus had been paused by U.S. health regulators over potential safety concerns.
  • Pauses to clinical trials are not uncommon, and the delays should reassure the public that the systems in place intended to protect volunteers are working, medical experts say.

Coronavirus clinical trials from drug giants Johnson & Johnson and Eli Lilly hit a snag this week after safety monitors halted them over bad reactions from participants.

J&J said Monday it paused the late-stage trial of its coronavirus vaccine candidate after a participant reported an “adverse event.” Less than 24 hours later, Eli Lilly said its late-stage trial of its leading monoclonal antibody treatment for the coronavirus had been paused by U.S. health regulators over potential safety concerns. The pauses are likely to add to concerns about the safeness of potential Covid-19 vaccines or treatments.

But pauses to clinical trials are not uncommon, and the delays should reassure the public that the systems in place intended to protect volunteers are working, medical experts said in phone interviews with CNBC.WATCH NOWVIDEO04:02Jim Cramer: Eli Lilly pausing antibody trial isn’t a big setback

The data and safety monitoring board, an independent group of experts who oversee U.S. clinical trials to ensure the safety of participants, recommends a pause to a clinical trial any time there is an “adverse event,” said Isaac Bogoch, an infectious disease specialist and professor at the University of Toronto. The pause will take as long as needed to gather all information and does not necessarily mean there is a problem with the vaccine or treatment, he said.

“The DSMB will say let’s push pause on this,” said Bogoch, who is also a member of the group and is overseeing other clinical drug trials. “They will say, ‘we need more data and let’s see if this person was in the vaccine group or in a placebo group.’ They’ll say, ‘let’s see what the actual illness is and use all the data at our disposal to determine whether this was a true side effect from the vaccine and if so, decide if it is safe to proceed with this study.’”

Pauses happen all the time, especially in large clinical trials with older adults, according to Dr. Paul Offit, director of the Vaccine Education Center at Children’s Hospital of Philadelphia.

Offit, a past member of the CDC’s Advisory Committee on Immunization Practices, said “adults get sick” and sometimes “they are going to get sick in the same period of time” of getting a vaccine or treatment.

“Johnson & Johnson’s vaccine is designed to prevent Covid-19. It is not designed to prevent everything else that happens in life,” he said. “You’re always going to be sorting out those temporal associations. Strokes, heart attacks, neurological problems. Always. You always err on the side of caution and make sure that this isn’t a problem and then continue again.”

Bogoch echoed those remarks, adding, “no one before Covid-19 cared when there was a pause on a clinical trial for an antibiotic or heart medication.”

“Never have we been in a scenario where you truly have 7 billion people watching intently and following every single bit of progress under a microscope,” he said. “You know, it’s fascinating and it’s good. It creates a more health literate community. There is only good that can come of it.”

He added a pause isn’t the same as a regulatory hold, sometimes referred to as a “clinical hold.”  A clinical hold is imposed by a health authority, like the Food and Drug Administration, he said.

“It’s a little more serious when you get to a regulatory hold,” he said. “That’s actually when the FDA steps in and say we’re concerned about a particular event and we’re going to stop this trial because we don’t think it’s safe to proceed with the data that we have available at this point in time.”

The FDA still has a late-stage clinical trial from AstraZeneca, a front-runner in the Covid-19 vaccine race, on hold in the United States. That means the company is unable to administer second doses of its two-dose vaccine regimen to U.S. participants.

The company announced on Sept. 8 that its trial had been put on hold due to an unexplained illness in a patient in the United Kingdom. The patient is believed to have developed inflammation of the spinal cord, known as transverse myelitis. The trial has since resumed in the U.K. and other countries but is still on hold in the U.S.

It remains unknown what reactions the participants in J&J’s and Eli Lilly’s trials had.

Offit said companies will sometimes claim they are protecting the confidentiality of the patient, but he disagreed with the behavior. “As long as you can’t identify the person, they can give you a fair amount of information about the person, but they don’t,” he said.

Dr. Mathai Mammen, global head of research and development at J&J’s Janssen arm, told investors on a conference call Tuesday that the company still had “very little information” on the reason for the holdup, including if the patient received the vaccine or the placebo. “It’ll be a few days at minimum for the right information to be gathered,” he added.

Dr. Ezekiel Emanuel, a former health advisor in the Obama administration, said it would “raise serious questions” if the participant received the vaccine.

“One adverse event is serious, especially when you’re considering a vaccine that you’re going to roll out to tens, hundreds of millions of people, maybe even billions,” he said Tuesday on CNBC’s “Squawk Box.” “That’s the ultimate concern.”

Eli Lilly and the National Institutes of Health did not disclose what the “safety” concern was either, but Eli Lilly said it was “supportive of the decision by the independent DSMB to cautiously ensure the safety of the patients participating in this study.”

“Safety is of the utmost importance to Lilly. We are aware that, out of an abundance of caution, the ACTIV-3 independent data safety monitoring board (DSMB) has recommended a pause in enrollment,” spokeswoman Molly McCully told CNBC. 

Indeed, the whole world is on edge for the first time in “modern” history with over 1 Million dead global (as reported by Wikipedia) from COVID 19 and even more cases. People are waiting for a solution and the end of the pandemic. How important is a vaccine to you and yours? Is a safe and effective vaccine more important to you than simply a vaccine? Will you take the vaccine once it is here?

Share your comments with the community by posting them below. Share the wealth of health with your friends and family by sharing this article with 3 people today. As always you are the best part of what we do. Keep sharing!

If these articles have been helpful to you and yours, give a donation to Shidonna Raven Garden and Cook Ezine today.

Posted on Leave a comment

Japan is Number 1: Recycling

Japan Shidonna Raven Garden and Cook

When one of our friends moved to Japan, one striking difference we noted was their (Japan’s) commitment to the environment: namely recycling. The OECD (Organisation for Economic Cooperation and Development (an intergovernmental organisation) named Japan as number one in landfills (in 2015). Japan has a rigorous recycling plan that leaves very little waste for landfills. Japan is also 19th in the world, according to OECD in 2015, for recycling and composting. We (the United States) are 54th and 35th respectively. But, with cities like San Francisco as shinning and positive and progressive examples, there is much hope for the United States to go from being the largest waste producers in the world to true leaders in progressive and positive environment change.

The City of Norfolk, VA, USA offers curbside or drop off recycling options for residence: Click Here to learn more! Composting offers the gardener a wonderful resource of nutrients for their plants. The same is true for grass (it is a plant. a large plant. but a plant). The fruits from compositing can provide one with chemical (depending on what you put in your composter) free fertilizers for their grass and save them a trip to the store by using sustainable resources such as leaves and used coffee grounds to feed nutrients back into beautifying their yards or feeding house plants. Countries like Japan and cities like San Francisco remind us just how possible and beneficial recycling can be.

What other ways do you use compost? How often have you bought fertilizer? What are the benefits and savings to you for recycling and composting not to mention the environment we live in?

Share your comments with the community by posting them below. Share the wealth of health with your friends and family by sharing this article with 3 people today. As always you are the best part of what we do. Keep sharing!

If these articles have been helpful to you and yours, give a donation to Shidonna Raven Garden and Cook Ezine today.

Posted on Leave a comment

We Can Solve This: Climate Change

We Can Solve This: San Francisco Leads the Way – Climate Change
Source: Climate Reality Project
Shidonna Raven Garden and Cook

This video reminds us just how possible it is to make negative climate change a thing of the past and how much we are already doing. As one of the largest (United States) producers of waste in the world, it makes us proud to see just how proactive San Francisco is. It is a beautiful city with good reason. Already many stores in the area have begun to make reusable bags a thing of the present while encouraging people to bring their own bags. On the Norfolk State University campus one can already see water fountains with refillable stations for water bottles like the one featured in the video. We have already invested in stainless steel water bottles made to last and with environmentally friendly materials (not plastic). In fact, many of the inititives to reduce waste are also a cost savings to both the consumer and the company as we move towards sustainable, realistic and options that are friendly to the environment that we live in.

In fact, these green solutions offer countless benefits: solar panels (which Prince Charles himself uses) as well as green roofs provide cost savings a responsible use of natural resources and fresh air not to mention the many other benefits green spaces offer humans. Recycling is nice. A nice way for tweens and teens to earn a little extra cash by turning recycled items in to establishments that still pay for these materials. The benefits are truly endless and a means that are sustainable. We could not be more excited about the example San Francisco offers to other cities and we are not far behind.

What are some ways that you contribute to the health of our environment? Do you have a water bottle? How often do you use it? We have been know to bring our water bottles to restaurants. Its not mainstream yet, but just wait.

Share your comments with the community by posting them below. Share the wealth of health with your friends and family by sharing this article with 3 people today. As always you are the best part of what we do. Keep sharing!

If these articles have been helpful to you and yours, give a donation to Shidonna Raven Garden and Cook Ezine today.

Posted on Leave a comment

Electric Cars: Tesla in Norfolk

Tesla Shidonna Raven Garden and Cook

A Tesla is a beautiful car (piece of machinery) made by a true engineer at heart. So, when you see a Tesla it is pretty hard to miss. And when you see a Tesla electric charging station it is even harder to miss. They are definitely unique structures that stand out. We have one right in Norfolk at the Janaf Shopping Center not far from the Walmart. Norfolk, VA, USA may have its climate change challenges, but it is also a dynamic and progressive city with several positive climate change initiatives that we will be talking about. We are super excited to be living in the city that we believe is a jewel among many jewels in the state of Virginia.

We are still driving vehicles that are not electric. But, we have been doing out homework. It is reported that most electric cars costs comparably more in the beginning. But, over time we hear that the savings in maintenance and to power (electric vs. gas) yields a savings that adds up over time. Additionally, FuelEconomy.gov reports that there are also possible tax breaks for having a electric vehicle. We will continue doing our research and hope that our next vehicle can be electric. As the technology grows there continues to be more options for consumers new and used.

Do you own an electric vehicle? How long have you had it? Do you plan on buying an electric vehicles? What other benefits have you identified? What adjustments did you have to make when you purchased your first electric vehicle?

Share your comments with the community by posting them below. Share the wealth of health with your friends and family by sharing this article with 3 people today. As always you are the best part of what we do. Keep sharing!

If these articles have been helpful to you and yours, give a donation to Shidonna Raven Garden and Cook Ezine today.